Dingli D, Matos JE, Lehrhaupt K, Krishnan S, et al. The burden of illness in patients with paroxysmal nocturnal hemoglobinuria receiving treatment with the C5-inhibitors eculizumab or ravulizumab: results from a US patient survey. Ann Hematol 2022;101:251-263.
PMID: 34973099